The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Thursday, January 30, 2020
Johnson & Johnson announced it is mobilizing resources at its Janssen Pharmaceutical to launch a multi-pronged response to the novel coronavirus ...
read more
Thursday, January 30, 2020
Spring Bank has discontinued development of inarigivir soproxil for the treatment of chronic hepatitis B virus (HBV).
read more
Wednesday, January 29, 2020
GeoVax Labs and BravoVax announced the signing of a Letter of Intent to jointly develop a vaccine against the new coronavirus (known as 2019-nCoV).
read more
Wednesday, January 29, 2020
Emerald Health announced the EMA has granted Orphan Designation for its product candidate, EHP-102, for the treatment of Huntington’s disease.
read more
Tuesday, January 28, 2020
Physicians and scientists at Rush University Medical Center found injecting tumors with influenza vaccines, including some FDA-approved seasonal flu ...
read more
Thursday, January 23, 2020
Supernus announced the FDA has found the NDA for SPN-812 for the treatment of children and adolescents with ADHD acceptable for review.
read more
Thursday, January 23, 2020
Inovio announced CEPI has awarded a grant to develop a vaccine against the recently emerged strain of coronavirus (2019-nCoV).
read more
Wednesday, January 22, 2020
The FDA has approved Tepezza (teprotumumab-trbw) for the treatment of adults with thyroid eye disease.
read more
Akero announced the ongoing Phase 2a BALANCED study of AKR-001 is being expanded to include an additional cohort of subjects with NASH who have ...
read more
Proteostasis announced a regulatory update following the completion of a scientific advice meeting with the MHRA, UK.
read more
In a split vote on the key question, six advisory committee members voted to recommend that the efficacy, safety, and overall risk-benefit profile of ...
read more
Thursday, January 16, 2020
COMPASS Pathways has been granted US Patent No 10,519,175, relating to methods of treating drug-resistant depression with a psilocybin formulation, by...
read more
Thursday, January 16, 2020
Arena announced the FDA granted Fast Track designation for APD418, a ß3-adrenergic receptor antagonist and cardiac myotrope, in development for the ...
read more
Tuesday, January 14, 2020
Retrotope has dosed its first patient in a Phase 2/3 clinical trial of RT001 in Friedreich’s ataxia, the most common of the inherited ataxias.
read more
Tuesday, January 14, 2020
Advanced BioMatrix has acquired the HyStem® line of products from Lineage Cell Therapeutics – previously BioTime/ESI Bio/Glycosan.
read more